Product Recalls, Relief Efforts, New Term Loans, Mixed Legal Verdict, and Product Launches - Research Report on Baxter, Covidien, Cooper, BD, and Teleflex

NEW YORK, September 30, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Baxter International Inc. (NYSE: BAX), Covidien plc (NYSE: COV), The Cooper Companies, Inc. (NYSE: COO), Becton, Dickinson and Company (NYSE: BDX), and Teleflex Incorporated (NYSE: TFX). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Baxter International Inc. Research Report

On September 19, 2013, Baxter International Inc. (Baxter) announced that it has initiated a voluntary recall of two lots of its Dual Luer Lock Caps due to the presence of loose particulate matter found in the packaging. As per Baxter, particulate matter entering the fluid path from the Luer Lock Caps may result in thrombotic and embolic events, including: pulmonary embolism, myocardial infarction and stroke. The Company said that there have been no reported complaints associated with the issue; however, embolic events may not be easily attributed to such particulate matter. The Company also informed that the root cause has been identified and resolved, and the FDA has designated the issue as a Class I recall. The Full Research Report on Baxter International Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/163d_BAX]

--

Covidien plc Research Report

On September 20, 2013, Covidien plc (Covidien) announced that it has donated $50,000 in support of relief efforts in flood-damaged communities in Colorado. Covidien has provided corporate grants totaling $50,000 and will match employee contributions to local relief efforts. Jose E. Almeida, Chairman, President and CEO of Covidien said, "We recognize the relief efforts are just beginning, but Covidien will continue to offer assistance through both our Company's contributions and the efforts of our employees." The Full Research Report on Covidien plc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/a14c_COV]

--

The Cooper Companies, Inc. Research Report

On September 16, 2013, The Cooper Companies, Inc. (Cooper) announced the closing of a $300 million 5-year Senior Unsecured Term Loan with a maturity date of September 12, 2018. The Company informed that it intends to use the facility for the payment of its borrowings under its $1 billion Senior Unsecured Revolving Line of Credit, which matures on May 31, 2017. Robert S. Weiss, President and CEO of Cooper said, "This Term Loan provides additional financial flexibility through an improved maturity structure, additional capacity and lower interest rates which will result in estimated interest expense savings, net of fees, of approximately $370,000 in fiscal 2014." The Full Research Report on The Cooper Companies, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/9cde_COO]

--

Becton, Dickinson and Company Research Report

On September 20, 2013, Becton, Dickinson and Company (BD) announced that a jury has returned a mixed verdict in the lawsuit filed against the Company by Retractable Technologies, Inc. (RTI) in the United States Court for the Eastern District of Texas. BD informed that the verdict was unfavorable to the Company with respect to RTI's Lanham Act claim and claim for attempted monopolization based on deception in the safety syringe market. "We're disappointed with the portion of the verdict that favored RTI, and we believe this aspect of the verdict was erroneous," said Jeffrey S. Sherman, Senior Vice President and General Counsel of BD. "We will file an appeal at the earliest opportunity." The Full Research Report on Becton, Dickinson and Company - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/0175_BDX]

--

Teleflex Incorporated Research Report

On September 19, 2013, Teleflex Incorporated (Teleflex) announced the launch of the new ARROW JACC with Chlorag+ard Technology, a small-french size antimicrobial and antithrombogenic catheter that is designed for both acute and long-term use. "This product's innovative design offers clinicians a new and unique treatment option that further demonstrates our commitment to achieve 'Zero Complications' in vascular access," said Benson Smith, Chairman, President, and CEO of Teleflex. "We believe the ARROW® JACC represents a significant step forward in raising the standard of care for patients requiring vascular access, while equally addressing the clinical need for treatment efficiency and cost-effectiveness in our challenging healthcare environment." The Full Research Report on Teleflex Incorporated - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/9c7d_TFX]

----

EDITOR NOTES:

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts' Corner